Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 22 hours ago

Indications

Topotecan for injection is used on its own for metastatic carcinoma of the ovary. It is given when the disease has progressed on or after initial or later chemotherapy. It is also used as a single agent for small cell lung cancer in patients with platinum-sensitive disease. These are patients whose disease progressed at least 60 days after first-line chemotherapy was started. For cervical cancer, topotecan for injection is given together with cisplatin. This applies to patients with Stage IV-B, recurrent or persistent carcinoma of the cervix that can't be treated with curative treatment.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Topotecan works in the same way as irinotecan. It is believed to damage cells mainly during the S-phase of DNA synthesis. Topoisomerase I eases the torsional strain in DNA by making reversible single strand breaks. Topotecan binds to the topoisomerase I-DNA complex and stops these single strand breaks from being religated.

The resulting ternary complex gets in the way of the moving replication fork. This leads to replication arrest and to lethal double-stranded breaks in DNA. Mammalian cells can't repair these double strand breaks efficiently, so the formation of the ternary complex eventually leads to apoptosis (programmed cell death).

Topotecan mimics a DNA base pair and binds at the site of DNA cleavage, where it intercalates between the upstream (-1) and downstream (+1) base pairs. This intercalation displaces the downstream DNA, so the cleaved strand can't be religated. Because Topotecan binds specifically to the enzyme-substrate complex, it acts as an uncompetitive inhibitor.

Pregnancy & Breastfeeding

Topotecan is in pregnancy category D. This means there is positive evidence of risk to the human foetus. Even so, a pregnant woman may still receive it if the benefit is acceptable despite that risk, for example when the medicine is needed in a life-threatening situation, or for a serious disease where safer drugs cannot be used or don't work.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Check the dose against the patient's body surface area before dispensing Topotecan. The dose should generally not exceed 4 mg intravenously. For ovarian cancer, the recommended dose is 1.5 mg/m² by intravenous infusion over 30 minutes, given daily for 5 consecutive days, starting on Day 1 of a 21-day course. Small cell lung cancer has the same dose of 1.5 mg/m² by intravenous infusion over 30 minutes daily for 5 consecutive days, starting on Day 1 of a 21-day course. For cervical cancer, the recommended dose of Topotecan is 0.75 mg/m² by intravenous infusion over 30 minutes daily on Days 1, 2 and 3. It is given in combination with cisplatin 50 mg/m² on Day 1, and the course is repeated every 21 days.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.

Key Interactions

Checker →